Scandion Oncology Balance Sheet Health
Financial Health criteria checks 4/6
Scandion Oncology has a total shareholder equity of DKK23.7M and total debt of DKK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are DKK28.4M and DKK4.7M respectively.
Key information
0%
Debt to equity ratio
DKK 0
Debt
| Interest coverage ratio | n/a |
| Cash | DKK 14.81m |
| Equity | DKK 23.70m |
| Total liabilities | DKK 4.69m |
| Total assets | DKK 28.39m |
Recent financial health updates
We Think Scandion Oncology (STO:SCOL) Needs To Drive Business Growth Carefully
Aug 02
Companies Like Scandion Oncology (STO:SCOL) Are In A Position To Invest In Growth
Feb 01Here's Why We're Not Too Worried About Scandion Oncology's (STO:SCOL) Cash Burn Situation
May 26We're Hopeful That Scandion Oncology (NGM:SCOL) Will Use Its Cash Wisely
Jan 06
Recent updates
We Think Scandion Oncology (STO:SCOL) Needs To Drive Business Growth Carefully
Aug 02Companies Like Scandion Oncology (STO:SCOL) Are In A Position To Invest In Growth
Feb 01Here's Why We're Not Too Worried About Scandion Oncology's (STO:SCOL) Cash Burn Situation
May 26We're Hopeful That Scandion Oncology (NGM:SCOL) Will Use Its Cash Wisely
Jan 06Financial Position Analysis
Short Term Liabilities: SCOL's short term assets (DKK22.6M) exceed its short term liabilities (DKK4.7M).
Long Term Liabilities: SCOL's short term assets (DKK22.6M) do not cover its long term liabilities (DKK-1,000.0).
Debt to Equity History and Analysis
Debt Level: SCOL is debt free.
Reducing Debt: SCOL had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SCOL has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: SCOL has sufficient cash runway for 2.1 years if free cash flow continues to reduce at historical rates of 25.4% each year.